SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-20-123897
Filing Date
2020-11-12
Accepted
2020-11-12 06:53:09
Documents
58
Period of Report
2020-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q tm2029580-1_10q.htm 10-Q 795577
2 EXHIBIT 10.1 tm2029580d1_ex10-1.htm EX-10.1 108933
3 EXHIBIT 31.1 tm2029580d1_ex31-1.htm EX-31.1 10173
4 EXHIBIT 32.1 tm2029580d1_ex32-1.htm EX-32.1 5318
  Complete submission text file 0001104659-20-123897.txt   5717578

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT lptx-20200930.xml EX-101.INS 1301334
6 XBRL TAXONOMY EXTENSION SCHEMA lptx-20200930.xsd EX-101.SCH 49987
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE lptx-20200930_cal.xml EX-101.CAL 47046
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE lptx-20200930_def.xml EX-101.DEF 186941
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE lptx-20200930_lab.xml EX-101.LAB 466119
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE lptx-20200930_pre.xml EX-101.PRE 339679
Mailing Address 47 THORNDIKE STREET SUITE B1-1 CAMBRIDGE MA 02142
Business Address 47 THORNDIKE STREET SUITE B1-1 CAMBRIDGE MA 02142 617 252 4343
LEAP THERAPEUTICS, INC. (Filer) CIK: 0001509745 (see all company filings)

IRS No.: 274412575 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37990 | Film No.: 201303244
SIC: 2834 Pharmaceutical Preparations